Literature DB >> 16550518

Near-total resolution of multicentric Castleman disease by prolonged treatment with thalidomide.

Cindi R Starkey, Nancy E Joste, Fa-Chyi Lee.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16550518     DOI： 10.1002/ajh.20538

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  9 in total

Review 1.  Castleman's disease: from basic mechanisms to molecular therapeutics.

Authors:  Hazem E El-Osta; Razelle Kurzrock
Journal:  Oncologist       Date:  2011-03-25

Review 2.  Castleman's disease--a two compartment model of HHV8 infection.

Authors:  Klaus-Martin Schulte; Nadia Talat
Journal:  Nat Rev Clin Oncol       Date:  2010-07-06       Impact factor: 66.675

3.  Does Kaposi's sarcoma predict multicentric Castleman disease in the presence of generalized lymphadenopathy?

Authors:  Homam Alkaied; Kassem Harris; Dany Elsayegh; Inga Khachaturova; Michael Awasum; Seema Varma
Journal:  Med Oncol       Date:  2011-04-07       Impact factor: 3.064

Review 4.  Multicentric Castleman's disease presenting with multiple nodes in lungs: a case report and literature review.

Authors:  Xuefeng Sun; Bing Han
Journal:  Int J Hematol       Date:  2008-09-26       Impact factor: 2.490

5.  Successful immunomodulatory therapy in castleman disease with paraneoplastic pemphigus vulgaris.

Authors:  Zsofia Miltenyi; Judit Toth; Andrea Gonda; Ildiko Tar; Eva Remenyik; Arpad Illes
Journal:  Pathol Oncol Res       Date:  2009-09       Impact factor: 3.201

Review 6.  Multicentric Castleman's disease: a challenging diagnosis.

Authors:  Györgyi Műzes; Ferenc Sipos; Judit Csomor; Lídia Sréter
Journal:  Pathol Oncol Res       Date:  2013-03-21       Impact factor: 3.201

Review 7.  TAFRO syndrome: current perspectives.

Authors:  Kentaro Sakashita; Kengo Murata; Mikio Takamori
Journal:  J Blood Med       Date:  2018-01-22

8.  The disease course of Castleman disease patients with fatal outcomes in the ACCELERATE registry.

Authors:  David C Fajgenbaum; Sheila K Pierson; Karan Kanhai; Adam Bagg; Daisy Alapat; Megan S Lim; Mary Jo Lechowicz; Gordan Srkalovic; Thomas S Uldrick; Frits van Rhee
Journal:  Br J Haematol       Date:  2022-05-04       Impact factor: 8.615

9.  International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease.

Authors:  Frits van Rhee; Peter Voorhees; Angela Dispenzieri; Alexander Fosså; Gordan Srkalovic; Makoto Ide; Nikhil Munshi; Stephen Schey; Matthew Streetly; Sheila K Pierson; Helen L Partridge; Sudipto Mukherjee; Dustin Shilling; Katie Stone; Amy Greenway; Jason Ruth; Mary Jo Lechowicz; Shanmuganathan Chandrakasan; Raj Jayanthan; Elaine S Jaffe; Heather Leitch; Naveen Pemmaraju; Amy Chadburn; Megan S Lim; Kojo S Elenitoba-Johnson; Vera Krymskaya; Aaron Goodman; Christian Hoffmann; Pier Luigi Zinzani; Simone Ferrero; Louis Terriou; Yasuharu Sato; David Simpson; Raymond Wong; Jean-Francois Rossi; Sunita Nasta; Kazuyuki Yoshizaki; Razelle Kurzrock; Thomas S Uldrick; Corey Casper; Eric Oksenhendler; David C Fajgenbaum
Journal:  Blood       Date:  2018-09-04       Impact factor: 25.476
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.